Catalyst Pharmaceuticals, Inc.
FIRDAPSE
Countdown
3055days
Catalyst readout · ~ Jan 1, 2035 estimated
What's at stake
A key catalyst for FIRDAPSE (its lead indication) is expected ~ Jan 1, 2035.
Primary source
· SEC 8-K
verified 2mo ago
“a specified date in January 2035, if approved by the U.S. Food and Drug Administration”